Peter van de Sande, Synaffix CEO

Synaf­fix joins forces with So­tio on $740M ADC li­cens­ing deal, plans ex­pan­sion af­ter Lon­za ac­qui­si­tion

Lon­za’s Synaf­fix is adding an­oth­er man­u­fac­tur­ing li­cens­ing part­ner­ship by se­cur­ing a $740 mil­lion deal with So­tio Biotech, which would al­low So­tio to use the Dutch com­pa­ny’s three-pronged ADC tech.

It’s been a busy year for Synaf­fix: It was ac­quired by Lon­za in June and the So­tio deal is its fifth new li­cens­ing deal of the year. Synaf­fix CEO Pe­ter van de Sande told End­points News the Lon­za ac­qui­si­tion will al­low the com­pa­ny to bol­ster its ADC ser­vices. This in­cludes plans to in­crease its per­son­nel count from 35 to 50 in the next year, as well as ex­pand its fa­cil­i­ties and in­crease its man­u­fac­tur­ing R&D ca­pac­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA